Berlin-based high-tech company Capsulution NanoScience AG has signed a cooperation agreement with the globally operating special chemicals corporation Cognis in December. As part of the agreement Capsulution will apply its proprietary LBL-Technologie® for the targeted development of new and innovative products. Further details of the agreement have not been disclosed.
Cognis - separated into the strategic business units Oleochemicals, Nutrition & Health, Care Chemicals, Functional Products and Process Chemicals - has generated a turnover in 2002 in excess of Euro 3 billion of which Euro 76 million have been spent on research and development. Current research and development activities focus on products and concepts for cosmetics, nutrition and healthcare, the research of innovative formulation concepts and delivery systems as well as on products with additional functionalities (e.g. textiles with skin-caring effects).
Alexander Herrmann, Chief Financial Officer of Capsulution commented on the recently signed cooperation agreement: "We are very pleased to have found with Cognis a globally renowned cooperation partner. Based on our expertise in the area of nano- and micro-encapsulation we will demonstrate yet another time, that we are capable to fulfil the demands of a globally-operation corporation in its search for innovative solution in a speedy and professional manner."